Contact Us

DESTINATION NEWS

SEMIFIVE Signs MOU with Atron Technologies to Collaborate on Semiconductor Design

May 30, 2024

Expected to expand global business in the Chinese market SEOUL,South Korea,May 24,2024-- SEMIFIVE,a leading design solution provider and pioneer of platform-based custom silicon solutions,has announc

COP29 Unveils Accommodation Platform

May 30, 2024

Portal Will Enable Participants and Attendees to Book Roomsfor November Event in Baku BAKU,Azerbaijan,May 24,2024-- Azerbaijan,the host of COP29,today unveiled its interactive accommodation portal,the

Recon Technology Regains Nasdaq Compliance; Hearing Moot

May 30, 2024

BEIJING,May 23,2024-- Recon Technology,Ltd. (NASDAQ: RCON) ("Recon" or the "Company") announced today that on May 22,2024,it had received a letter dated May 22,2024 (the "Comp

Ultima Markets partnered with Willis Towers Watson (WTW) to offer US$1 million in fund insurance

May 30, 2024

EBENE CYBERCITY,Mauritius,May 24,2024-- Ultima Markets,one of the fastest-growing online trading brokers,is proud to announce its partnership with Willis Towers Watson (WTW) to enhance its client\'s

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

May 30, 2024

SUZHOU,ChinaandROCKVILLE,Md.,May 24,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in developing novel therapies for cancer,chronic hepatitis B (CHB),and age-related dis

Antengene To Present One Oral and Four Abstracts at ASCO 2024

May 30, 2024

Oral Presentation:a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer

1 ... 331 332 333 334 335 336 337 ... 348